← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2002Last known activity
Aug 7, 2023
Timeline
1960s
- Jun 1, 1960
Bukwang Pharmaceutical— Founded
2010s
- Nov 28, 2014
Contera Pharma— Acquired
Drugs by trial phase (19 distinct, 37 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 1 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Hepatocellular
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Dyskinesia, Drug-Induced
- Dyskinesias
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis, Chronic
- Irritable Bowel Syndrome
- Mental Disorders
- Parkinson Disease
- Psychotic Disorders
- Schizophrenia
- Spinal Cord Injuries
- Stomach Neoplasms
- Syndrome
- Wounds and Injuries
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (37)
- NCT06014853Lead sponsorPhase 1Aug 7, 2023
- NCT04891302Lead sponsorPhase 2Mar 19, 2021
- NCT04377945Study directorPhase 2Jun 1, 2020
- NCT04377945Lead sponsorPhase 2Jun 1, 2020
- NCT04347915Lead sponsorPhase 2Apr 24, 2020
- NCT03956979CollaboratorPhase 2Jul 31, 2019
- NCT03465787Lead sponsorPhase 3Apr 9, 2018
- NCT03279263CollaboratorPhase 2Sep 30, 2017
- NCT02711969Lead sponsorPhase 1Mar 1, 2016
- NCT02439203Lead sponsorPhase 2May 1, 2015
- NCT02317796CollaboratorPhase 2Dec 1, 2014
- NCT01581242Lead sponsorPhase 1Apr 1, 2012
- NCT01497704CollaboratorPhase 1/Phase 2Apr 1, 2012
- NCT01624779Lead sponsorPhase 1Apr 1, 2012
- NCT01507922Lead sponsorPhase 4Dec 1, 2011
Details
- Founded
- Seoul, KR Jun 1, 1960
- Last known activity
- Aug 7, 2023